Escalon Medical Corp.
Cash Flow Statement
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $2.4M | $97.7K | $-239.9K | $-379.8K | $271.5K | $246.0K | $-32.2K | $134.4K |
| Depreciation & Amortization | $3.0K | $8.4K | $8.2K | $8.6K | $8.8K | $9.9K | $10.6K | $19.3K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $281.0K | $-517.4K | $85.0K | $15.8K | $30.7K | $300.9K | $33.3K | $-339.9K |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $4.4K | $3.9K | $0 | $0 | $0 | $9.2K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $2.8M | $0 | $-4.4K | $-3.9K | $0 | $0 | $0 | $-9.2K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-100.9K | $-17.5K | $-10.6K | $-6.9K | $-10.3K | $-10.0K | $-12.6K | $-6.5K |
| Net Change in Cash | $3.0M | $-534.9K | $70.0K | $5.0K | $20.4K | $290.9K | $20.7K | $-355.6K |
| Free Cash Flow | $281.0K | $-517.4K | $80.6K | $11.9K | $30.7K | $300.9K | $33.3K | $-349.1K |